Eli Lilly and Company (LLY) Balance Sheet
As of 2026-06-30 (10-Q), Eli Lilly and Company (LLY) reported total assets of $142.3B and shareholders' equity of $33.9B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $8.9B. Long-term debt: $47.9B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LLYEli Lilly and CompanyFollow LLY — free
—
Price chart with a free account
- Market cap
- 1.20T
- P/E TTM
- 42.7
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.46 | 5.99 | 5.92 | 4.02 | 3.83 | 3.87 | 3.67 | 4.58 | 6.54 | 7.32 | 2.34 | 3.66 | 3.82 | 2.07 | 2.82 | 3.27 | 7.27 | 8.95 | |
| Short-term investments | 0.03 | 0.73 | 0.97 | 1.67 | 1.57 | 0.96 | 0.79 | 1.46 | 1.50 | 0.09 | 0.10 | 0.02 | 0.09 | 0.14 | 0.11 | 0.15 | — | — | |
| Receivables | 3.34 | 3.49 | 3.60 | 3.34 | 3.43 | 3.23 | 3.51 | 4.03 | 4.55 | 4.59 | 4.55 | 5.88 | 6.67 | 6.90 | 9.09 | 11.01 | 17.76 | 20.08 | |
| Inventory | 2.85 | 2.52 | 2.30 | 2.64 | 2.93 | 2.74 | 3.45 | 3.56 | 4.46 | 3.10 | 3.19 | 3.98 | 3.89 | 4.31 | 5.77 | 7.59 | 13.74 | 16.79 | |
| Current assets | 12.49 | 14.84 | 14.25 | 13.04 | 13.10 | 11.93 | 12.57 | 15.10 | 19.20 | 20.55 | 13.71 | 17.46 | 18.45 | 18.03 | 25.73 | 32.74 | 55.63 | 64.67 | |
| Total assets | 27.46 | 31.00 | 33.66 | 34.40 | 35.25 | 36.31 | 35.57 | 38.81 | 44.98 | 43.91 | 39.29 | 46.63 | 48.81 | 49.49 | 64.01 | 78.72 | 112.48 | 142.28 | |
| Current liabilities | 6.57 | 6.93 | 8.93 | 8.39 | 8.92 | 9.74 | 8.23 | 10.99 | 14.54 | 11.89 | 11.78 | 12.48 | 15.05 | 17.14 | 27.29 | 28.38 | 35.23 | 47.74 | |
| Long-term debt | 6.63 | 6.77 | 5.46 | 5.52 | 4.20 | 5.33 | 7.97 | 8.37 | 9.94 | 9.20 | 13.82 | 16.59 | 15.35 | 14.74 | 18.32 | 28.53 | 40.87 | 47.86 | |
| Short-term debt | -0.02 | 0.02 | 1.52 | 0.01 | 1.01 | 2.69 | 0.01 | 1.94 | 3.71 | 1.10 | 1.50 | 0.01 | 1.54 | 1.50 | 6.90 | 5.12 | 1.64 | 7.05 | |
| Shareholders' equity | 9.53 | 12.42 | 13.54 | 14.77 | 17.63 | 15.37 | 14.57 | 14.01 | 11.59 | 9.83 | 2.61 | 5.64 | 8.98 | 10.65 | 10.77 | 14.27 | 26.54 | 33.88 |
USD billions · SEC XBRL
Eli Lilly and Company — questions
- How much cash does Eli Lilly and Company have?
- $8.9B in cash and cash equivalents as of 2026-06-30.
- How much debt does Eli Lilly and Company have?
- $47.9B of long-term debt and $7.0B due within a year as of 2026-06-30.
- What are Eli Lilly and Company's total assets?
- $142.3B as of 2026-06-30.
- What is Eli Lilly and Company's shareholders' equity?
- $33.9B as of 2026-06-30.
Every figure on this page comes from Eli Lilly and Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.